Maynard Um
-
-
-
-
-
-
-
Biofrontera Inc. (BFRI) Misses Q3 EPS by 62c
-
-
-
-
-
-
-
Biofrontera Inc. (BFRI) Announces Patent for Propylene Glycol-Free Formula of AmeluzĀ® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book
-
-
-
-
-
-
-
Biofrontera Inc. (BFRI) Announces 100 RhodoLED XL Machines Now Placed in US Market
-
-
-
-
-
-
-
Biofrontera (BFRI): FDA Approves Use of Up To Three Tubes of Ameluz Topical Gel, 10% In One Treatment
-
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

